Post-Authorization Activity Table (PAAT) for Tafinlar

Health Canada Post-Authorization Activity Table 2019-01-15, Tafinlar, 50 mg, 75 mg, dabrafenib (as dabrafenib mesylate), capsule, Novartis Pharmaceuticals Canada Inc.